> For the complete documentation index, see [llms.txt](https://bdcatalyst.gitbook.io/biodata-catalyst-documentation/llms.txt). Markdown versions of documentation pages are available by appending `.md` to page URLs; this page is available as [Markdown](https://bdcatalyst.gitbook.io/biodata-catalyst-documentation/written-documentation/release-notes/2026-07-15-bdc-ecosystem-release-notes.md). # 2026-07-15 BDC Ecosystem Release Notes 2026-07-15 BDC Ecosystem Release Notes ### Introduction The 2026-07-15 release marks the 25th update to the BDC ecosystem. This release introduces new features, including PIC-SURE “and” and “or” feature which allows researchers to build advanced queries. The 2026-07-15 data releases include the addition of 140 new datasets. See the Data Releases section below for more information. ### Significant new features The following new features were released this quarter to improve the researcher experience: #### BDC Seven Bridges Platform (BDC-Seven Bridges) * No significant new features to report for BDC-Seven Bridges #### BDC PIC-SURE Platform (BDC-PIC-SURE) * Build Cohorts with Advanced Queries: Researchers can now build advanced queries in PIC-SURE, combining logical operators (“and” and “or”) and grouping related variable-level filters. This tool enables researchers to create complex cohorts for analysis, visualize the variable distributions from these cohorts, and combine variable filters across multiple studies. #### BDC Terra Platform (BDC-Terra) * No significant new features to report for BDC-Terra #### BDC Gen3 Platform (BDC-Gen3) * No significant new features to report for BDC-Gen3 #### Data Releases The table below highlights which studies were included in the data releases in the months of May, June, and July 2026. May 2026 | Study Name | phs I.D. # | | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ------------------------------------------------------------- | | NHLBI TOPMed: Determining the Association of Chromosomal Variants with Non-PV Triggers and Ablation-Outcome in AF (DECAF) | phs001546.v3.p1.c1 | | NHLBI TOPMed: Children's Health Study (CHS) Effects of Air Pollution on the Development of Obesity in Children (Meta-AIR) | phs001604.v3.p1.c1 | | NHLBI TOPMed: The Genetic Causes of Unexplained Cardiomyopathies (UNID\_CM) | phs002382.v1.p1.c1 | | NIH RECOVER-Pediatric: Understanding the Long-Term Impact of COVID on Children and Families | phs003461.v4.p4.c1 | | NIH RECOVER: A Multi-Site Observational Study of Post-Acute Sequelae of SARS-CoV-2 Infection in Adults | phs003463.v6.p4.c1 | | Studies of Left Ventricular Dysfunction (SOLVD-BioLINCC) | phs003668.v2.p1.c1 | | NIH RECOVER: A Multi-Site Pathology Study of Post-Acute Sequelae of SARS-CoV-2 Infection | phs003768.v4.p2.c1 | | Hemochromatosis and Iron Overload Screening Study (HEIRS-BioLINCC) | phs004477.v1.p1.c1 | | Dietary Intervention Study in Children (DISC-BioLINCC) | phs004495.v1.p1.c1 | | Retrovirus Epidemiology Donor Study-II (REDS II) Donor Iron Status Evaluation Study (RISE) (REDS\_II\_RISE -BioLINCC) | phs004507.v1.p1.c1 | | Retrovirus Epidemiology Donor Study-II (REDS II) Molecular Surveillance (MS) - (REDS\_II\_MS\_BioLINCC) | phs004524.v1.p1.c1 | | Retrovirus Epidemiology Donor Study-II (REDS II) Natural History of Disease and Laboratory Findings in Trypanosoma Cruzi Antibody-Positive Brazilian Blood Donors (CHAGAS) (REDS\_II\_CHAGAS\_BioLINCC) | phs004528.v1.p1.c1 | | Natural History Study of Non-A, Non-B Post-Transfusion Hepatitis (NANB-TAH\_BioLINCC) | phs004538.v1.p1.c1 | | Novel Influenza A Surveillance Registry (H1N1\_BioLINCC) | phs004540.v1.p1.c1 | | New Data Analysis Methods for Actigraphy in Sleep Medicine (MASM\_BioLINCC) | phs004541.v1.p1.c1 | | Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial (NINDS-SHINE) | phs004544.v1.p1.c1 | | Heparin-Induced Thrombocytopenia - Retrospective Analysis of Data on Incidence and Outcomes Study (HIT\_RADIO\_BioLINCC) | phs004545.v1.p1.c1 | | Myocardial Ischemia and Transfusion (MINT) Trial | phs004546.v1.p1.c1 | | Thrombolysis in Myocardial Infarction (TIMI) (TIMI\_II\_BioLINCC) | phs004550.v1.p1.c1 | | Dietary Approaches to Stop Hypertension (DASH) (DASH\_BioLINCC) | phs004553.v1.r1.c1 | | Systolic Hypertension in the Elderly Program (SHEP\_BioLINCC) | phs004555.v1.p1.c1 | | Trials of Hypertension Prevention (TOHP\_BioLINCC) | phs004556.v1.p1.c1 | | Viral Activation Transfusion Study (VATS-BioLINCC) | phs004557.v1.p1.c1 | | Trial to Reduce Alloimmunization to Platelets (TRAP\_BioLINCC) | phs004558.v1.p1.c1 | | Practice Based Opportunities for Weight Reduction Trial at the University of Pennsylvania (POWER\_UP\_BioLINCC) | phs004559.v1.p1.c1 | | ToRsemide compArisoN With furoSemide FOR Management of Heart Failure (TRANSFORM-HF-BioLINCC) | phs004560.v1.p1.c1 | | AsthmaNet Proof of Concept Study of Alendronate for Asthma (ALFA\_BioLINCC) | phs004561.v1.p1.c1 | | Prevention of Events with Angiotensin-Converting Enzyme Inhibitor Therapy (PEACE\_BioLINCC) | phs004562.v1.p1.c1 | | Anti-HIV Immunoglobulin in Prevention of Maternal-Fetal HIV Transmission: Pediatric AIDS Clinical Trials Group protocol 185 (PACTGP-BioLINCC) | phs004581.v1.p1.c1 | | AsthmaNet -APRIL and Oral Corticosteroids for Treating Episodes of Significant Lower Respiratory Tract Symptoms in Children (OCELOT) | phs004582.v1.p1.c1 | | AsthmaNet Individualized Therapy for Asthma in Toddlers (INFANT) and Acetaminophen versus Ibuprofen in Children with Asthma (AVICA-BioLINCC) | phs004584.v1.p1.c1 | | AsthmaNet Best African American Response to Asthma Drugs (BARD-BioLINCC) | phs004585.v1.p1.c1 | | AsthmaNet Vitamin D Add-on Therapy Enhances Corticosteroid Responsiveness in Asthma (VIDA-BioLINCC) | phs004587.v1.p1.c1 | | Lipid Research Clinics (LRC) Coronary Primary Prevention Trial (CPPT-BioLINCC) | phs004589.v1.p1.c1 | | Prospective Multi-Center Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT-BioLINCC) | phs004590.v1.p1.c1 | | NHLBI TOPMed: Trans-Omics Analysis for Congestive Heart Failure (TOPCHeF) | phs002038.v1.p1.c1 | | NHLBI TOPMed: SubPopulations and InteRmediate Outcome Measures In COPD Study (SPIROMICS) | phs001927.v2.p2.c1 | | NHLBI TOPMed - NHGRI CCDG: Hispanic Community Health Study/Study of Latinos (HCHS/SOL) |

phs001395.v3.p2.c1

phs001395.v3.p2.c2


| | NHLBI TOPMed: Genetic Causes of Complex Pediatric Disorders - Asthma (GCPD-A) | phs001661.v4.p1.c1 | | NHLBI TOPMed: Genomic Activities such as Whole Genome Sequencing and Related Phenotypes in the Framingham Heart Study |

phs000974.v6.p5.c1

phs000974.v6.p5.c2

| | NHLBI TOPMed: Genetic Epidemiology of COPD (COPDGene) |

phs000951.v6.p5.c1

phs000951.v6.p5.c2

| | NHLBI TOPMed: Coronary Artery Risk Development in Young Adults (CARDIA) |

phs001612.v3.p3.c1

phs001612.v3.p3.c2

| | NHLBI TOPMed: Study of African Americans, Asthma, Genes and Environment (SAGE) | phs000921.v5.p2.c2 | | NHLBI TOPMed - NHGRI CCDG: Genes-Environments and Admixture in Latino Asthmatics (GALA II) | phs000920.v6.p4.c2 | | NHLBI TOPMed: MESA and MESA Family AA-CAC |

phs001416.v4.p1.c1

phs001416.v4.p1.c2

| | Women’s Health Initiative Clinical Trial and Observational Study-BioLINCC (WHI-BioLINCC) |

phs004266.v1.p1.c1

phs004266.v1.p1.c2

| June 2026 | Study Name | phs I.D. # | | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ---------------------------------------------------------------------------------------------------- | | NHLBI GO-ESP Lung Cohorts Exome Sequencing Project: Genetic modifiers of Pseudomonas aeruginosa (Pa) lung infection acquisition in cystic fibrosis |

phs000254.v2.p1.c1

phs000254.v2.p1.c2


| | Atherosclerosis Risk in Communities (ARIC) Cohort |

phs000280.v9.p3.c1

phs000280.v9.p3.c2

| | NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (Siblings with Ischemic Stroke Study, SWISS) | phs000327.v1.p1.c1 | | NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (Ischemic Stroke Genetic Study, ISGS) | phs000546.v1.p1.c1 | | NHLBI GO-ESP: Family Studies (Familial Interstitial Pneumonia) | phs000582.v1.p1.c1 | | Myocardial Infarction Genetics Exome Sequencing Consortium: Precocious Coronary Artery Disease Study | phs000883.v1.p1.c1 | | Myocardial Infarction Genetics Exome Sequencing Consortium: German Heart Center in Munich | phs000916.v1.p1.c1 | | NHLBI TOPMed: Genetics of Cardiometabolic Health in the Amish | phs000956.v6.p1.c2 | | NHLBI TOPMed: The Jackson Heart Study (JHS) |

phs000964.v6.p2.c1

phs000964.v6.p2.c2

phs000964.v6.p2.c3

phs000964.v6.p2.c4

| | Myocardial Infarction Genetics Exome Sequencing Consortium: U. of Leicester |

phs001000.v1.p1.c1

phs001000.v1.p1.c2

| | NIDDM-Atherosclerosis Study (NIDDM-Athero) | phs001130.v1.p1.c1 | | NHLBI TOPMed: African American Sarcoidosis Genetics Resource | phs001207.v4.p1.c1 | | NHLBI TOPMed: San Antonio Family Heart Study (SAFHS) | phs001215.v5.p2.c1 | | NextGen Consortium: The iPSCORE (iPSC Collection for Omic Research) Resource for Studying the Impact of Genetic Variation on Molecular and Physiological Phenotypes - Whole Genome Sequence |

phs001325.v6.p1.c1

phs001325.v6.p1.c2

phs001325.v6.p1.c3

| | NHLBI TOPMed: Diabetes Heart Study (DHS) African American Coronary Artery Calcification (AA CAC) |

phs001412.v4.p1.c1

phs001412.v4.p1.c2

| | Center for Common Disease Genomics (CCDG)-Cardiovascular: University of Pennsylvania Cohort | phs001502.v1.p1.c1 | | NHLBI TOPMed: Pediatric Asthma Controller Trial (PACT) | phs001730.v3.p1.c2 | | NHLBI Recipient Epidemiology Donor Evaluation Study (REDS)-III - Red Blood Cell Omics (RBC-Omics) Study | phs001955.v1.p1.c1 | | NHLBI TOPMed: Genomic Summary Results for the Trans-Omics for Precision Medicine Program | phs001974.v9.p1.c1 | | Interruption of BTK Inhibitor Improves Response to SARS-CoV-2 Booster Vaccination in Patients with Chronic Lymphocytic Leukemia | phs003319.v1.p1.c1 | | Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2-BioLINCC) | phs004322.v1.p1.c1 | | Longitudinal Studies of HIV-Associated Lung Infections and Complications (Lung HIV-BioLINCC) | phs004323.v1.p1.c1 | | The ARDS, Pneumonia, and Sepsis (APS) Consortium | phs004492.v1.p1.c1 | | Dietary Intervention Study in Children Follow-Up Study (DISC06-BioLINCC) |

phs004554.v1.p1.c1

phs004554.v1.p1.c2

| | Prevention and Treatment of Hypertension Study (PATHS\_BioLINCC) | phs004564.v1.p1.c1 | | Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS-BioLINCC) |

phs004568.v1.p1.c1

phs004568.v1.p1.c2

phs004568.v1.p1.c3

phs004568.v1.p1.c4

| | Proteomic Biomarkers of Survival in Idiopathic Pulmonary Fibrosis (IPF Survival Proteomics-BioLINCC) | phs004591.v1.p1.c1 | | REHAB-PH Omics Study | phs004597.v1.p1.c1 | | Bypass Angioplasty Revascularization Investigation (BARI-BioLINCC) | phs004599.v1.p1.c1 | | Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes (BARI2D-BioLINCC) | phs004600.v1.p1.c1 | | Blood and Marrow Clinical Trials Network (BMT CTN) Comparing Peripheral Blood Stem Cell Transplantation versus Bone Marrow Transplantation in Individuals With Hematologic Cancers (0201) (BMT-CTN-BioLINCC) | phs004601.v1.p1.c1 | | Cord Blood Transplantation Study (COBLT-BioLINCC) | phs004602.v1.p1.c1 | | Heart Healthy Lenoir Project (HHL-BioLINCC) | phs004603.v1.p1.c1 | | Innovative Approaches for Diet, Exercise, and Activity (IDEA-BioLINCC) | phs004604.v1.p1.c1 | | AsthmaNet Steroids in Eosinophil Negative Asthma (SIENA-BioLINCC) | phs004606.v1.p1.c1 | | AsthmaNet Step-up Yellow Zone Inhaled Corticosteroids to Prevent Exacerbations (STICS-BioLINCC) | phs004607.v1.p1.c1 | | Multiple Risk Factor Intervention Trial for the Prevention of Coronary Heart Disease (MRFIT-BioLINCC) | phs004609.v1.p1.c1 | | Optimal Macronutrient Intake Trial to Prevent Heart Disease (OMNI Heart-BioLINCC) | phs004610.v1.p1.c1 | | PREMIER: Lifestyle Interventions for Blood Pressure Control (PREMIER-BioLINCC) | phs004617.v1.p1.c1 | | "A Double Blind Randomized Controlled Trial to Assess the Efficacy and Safety of a Quadruple Ultra-low-dose Treatment for Hypertension (QUARTETUSA-BioLINCC) | phs004618.v1.p1.c1 | | Blood and Marrow Clinical Trials Network (BMT CTN) A Phase III Randomized, Multicenter Trial Comparing Sirolimus/Tacrolimus With Tacrolimus/Methotrexate as Graft-versus-Host Disease Prophylaxis After HLA-Matched, Related Peripheral Blood Stem Cell Transplantation (BMT-CTN-0402-BioLINCC) | phs004629.v1.p1.c1 | | Comparing Individualized versus Weight Based Protocols to Treat Vaso-Occlusive Episodes in Sickle Cell Disease (COMPARE-VOE-BioLINCC) | phs004630.v1.p1.c1 | | VA Cooperative Study of the Efficacy of Hepatitis Immune Serum Globulin for the Prevention or Modification of Post-Transfusion Hepatitis (VA2-TAH-BioLINCC) | phs004633.v1.p1.c1 | | Clarification of Optimal Anticoagulation through Genetics (COAG) (COAG-BioLINCC) | phs004634.v1.p1.c1 | | Dietary Approaches to Stop Hypertension - Sodium Study (DASH-Sodium-BioLINCC) | phs004635.v1.p1.c1 | | Weight Loss Maintenance (WLM-BioLINCC) | phs004636.v1.p1.c1 | | Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM-BioLINCC) | phs004639.v1.p1.c1 | | Blood and Marrow Transplant Clinical Trials Network - Randomized Multicenter Trial Comparing Sirolimus Plus Prednisone and Sirolimus/Calcineurin Inhibitor Plus Prednisone for the Treatment of Chronic Graft-versus-Host Disease (BMT-CTN-0801-BioLINCC) | phs004641.v1.p1.c1 | | Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Reduced Intensity Conditioning for Children and Adults With Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (1204)(BMT-CTN-1204-BioLINCC) | phs004642.v1.p1.c1 | | Post Coronary Artery Bypass Graft Study (CABG-BioLINCC) | phs004643.v1.p1.c1 | | Therapeutic Hypothermia After Pediatric Cardiac Arrest (In-Hospital) (THAPCA-IH-BioLINCC) | phs004645.v1.p1.c1 | | Therapeutic Hypothermia After Pediatric Cardiac Arrest (Out of Hospital) (THAPCA-OH-BioLINCC) | phs004646.v1.p1.c1 | | Coronary Artery Surgery Study (CASS-BioLINCC) | phs004647.v1.p1.c1 | July 2026 | Study Name | phs I.D. # | | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | | NHLBI GO-ESP: Family Studies (Thoracic aortic aneurysms leading to acute aortic dissections) | phs000347.v1.p1.c1 | | NHLBI GO-ESP: Family Studies (JHMI-Molecular Genetics of Atypical Cystic Fibrosis (CF) Study) | phs000556.v1.p1.c1 | | NHLBI GO-ESP: Family Studies (Hematological Cancers) | phs000632.v1.p1.c1 | | NextGen Consortium: The iPSCORE (iPSC Collection for Omic Research) Resource for Studying the Impact of Genetic Variation on Molecular Phenotypes |

phs000924.v6.p2.c1

phs000924.v6.p2.c2

phs000924.v6.p2.c3

| | Cardiac Arrhythmia Suppression Trial (CAST-BioLINCC) | phs004651.v1.p1.c1 | | Cardiovascular Cell Therapy Research Network - A Randomized, Controlled, Phase II, Double-Blind Trial of Intramyocardial Injection of Autologous Bone Marrow Mononuclear Cells Under Electromechanical Guidance for Patients With Chronic Ischemic Heart Disease and Left Ventricular Dysfunction (CCTRN-FOCUS-BioLINCC) | phs004652.v1.p1.c1 | | AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke (NINDS-ARCADIA) | phs004653.v1.p1.c1 | | AsthmaNet Airway Microbiome in Asthma: Relationships to Asthma Phenotype and Inhaled Corticosteroid Treatment (AsthmaNet Microbiome-BioLINCC) | phs004660.v1.p1.c1 | | Activity Counseling Trial (ACT-BioLINCC) | phs004661.v1.p1.c1 | | CCTRN -Transplantation in Myocardial Infarction Evaluation (TIME) Evaluating the Effect of Timing on the Administration BMMNCs Versus Placebo in Patients with Acute Myocardial Infarction (CCTRN-TIME-BioLINCC) | phs004668.v1.p1.c1 | | Effect of Positive Airway Pressure on Reducing Airway Reactivity in Patients with Asthma (CPAP-BioLINCC) | phs004676.v1.p1.c1 | | MEDication Focused Outpatient Care for Underutilization of Secondary Prevention (MEDFOCUS-BioLINCC) | phs004680.v1.p1.c1 | | Randomized Order Safety Trial Evaluating Resident-physician Schedules Study (ROSTERS) | phs004681.v1.p1.c1 | | Study of Novel Approaches for Prevention (SNAP-BioLINCC) | phs004682.v1.p1.c1 | | The Study of Soy Isoflavones in Asthma (SOYA-BioLINCC) | phs004683.v1.p1.c1 | | Trial to Assess Chelation Therapy (TACT-BioLINCC) | phs004684.v1.p1.c1 | | Resuscitation Outcomes Consortium (ROC) Pragmatic Randomized Optimal Platelet and Plasma Ratios (PROPPR-BioLINCC) | phs004685.v1.p1.c1 | | Recipient Epidemiology and Donor Evaluation Study III Vein to Vein Databases (REDS III-BioLINCC) | phs004687.v1.p1.c1 | | Transfusion Medicine and Hemostasis Clinical Trial Network - Red Cell Storage Duration Study (TMH-CTN-RECESS-BioLINCC) | phs004690.v1.p1.c1 | | Blood and Marrow Transplant Clinical Trials Network A Trial of Single Autologous Transplant With or Without Consolidation Therapy Versus Tandem Autologous Transplant With Lenalidomide Maintenance for Patients With Multiple Myeloma (BMT CTN-0702-BioLINCC) | phs004692.v1.p1.c1 | | Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglyceride and Impact on Global Health Outcomes (AIM-HIGH-BioLINCC) | phs004693.v1.p1.c1 | | Dietary Effects on Lipoproteins and Thrombogenic Activity (DELTA-BioLINCC) | phs004695.v1.p1.c1 | | Blood and Marrow Clinical Trials Network - Allogeneic Hematopoietic Cell Transplant for Hematological Cancers and Myelodysplastic Syndromes in HIV-Infected Individuals (BMT CTN-0903-BioLINCC) | phs004697.v1.p1.c1 | | Blood and Marrow Clinical Trials Network - A Multi-Center, Phase III, Randomized Trial of RIC, and Transplantation of (dUCB) Versus HLA-Haplo Related Bone Marrow for Patients with Hematologic Malignancies (BMT CTN-1101-BioLINCC) | phs004698.v1.p1.c1 | | Blood and Marrow Clinical Trials Network - Prospective Multi-Center Cohort for the Evaluation of Biomarkers Predicting Risk of Complications and Mortality Following Allogeneic HCT (BMT CTN-1202-BioLINCC) | phs004701.v1.p1.c1 | | Blood and Marrow Clinical Trials Network - Calcineurin Inhibitor-Free Interventions for Prevention of Graft-versus-Host Disease (BMT CTN-1301-BioLINCC) | phs004703.v1.p1.c1 | | Blood and Marrow Clinical Trials Network - A Study Evaluating Sirolimus and Prednisone in Patients With Refined Minnesota Standard Risk, Ann Arbor 1/2 Confirmed Acute Graft-Versus-Host Disease (BMT CTN-1501-BioLINCC) | phs004704.v1.p1.c1 | | Blood and Marrow Clinical Trials Network - Multicenter Phase II, Double-blind Placebo Controlled Trial of Maintenance Ixazomib After Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Multiple Myeloma (BMT CTN-1302-BioLINCC) | phs004705.v1.p1.c1 | | Cardiothoracic Surgical Trials Network (CTSN) Neuroprotection in Patients Undergoing Aortic Valve Replacement (CTSN-NP-BioLINCC) | phs004707.v1.p1.c1 | | Blood and Marrow Clinical Trials Network - A Multi-center Phase II Trial Randomizing Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN-1203-BioLINCC) | phs004709.v1.p1.c1 | | Blood and Marrow Clinical Trials Network - Optimizing Haploidentical Aplastic Anemia Transplantation (CHAMP) (BMT CTN-1502-BioLINCC) | phs004710.v1.p1.c1 | | Blood and Marrow Transplant Clinical Trials Network - A Trial of Tac/MTX versus PTCy/Tac/MMF in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT-CTN-1703-BioLINCC) | phs004711.v1.p1.c1 | | Cardiovascular Cell Therapy Research Network (CCTRN) - A Phase I Study of the Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Cancer Survivors With Anthracycline-Induced Cardiomyopathy (CCTRN-SENECA-BioLINCC) | phs004712.v1.p1.c1 | | Cardiothoracic Surgical Trials Network + Cardiovascular Cell Therapy Research Network Left Ventricular Assist Device Therapy:Exploring the Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function (CTSN-CCTRN-LVAD-BioLINCC | phs004714.v1.p1.c1 | | Blood and Marrow Transplant Clinical Trials Network - Single Autologous Hematopoietic Cell Transplant Followed by Lenalidomide Maintenance for Multiple Myeloma With or Without Vaccination With Dendritic Cell/Myeloma Fusions (BMT CTN-1401-BioLINCC) | phs004718.v1.p1.c1 | | Blood and Marrow Clinical Trials Network A Study to Compare Bone Marrow Transplantation to Standard Care in Adolescents and Young Adults with Severe Sickle Cell Disease (BMT-CTN-1503-BioLINCC) | phs004720.v1.p1.c1 | |

mproving Outcomes After Pediatric Cardiac Arrest (ICU-RESUS-BioLINCC)


| phs004721.v1.p1.c1 | | Genetic Epidemiology of COPD (COPDGene) Funded by the National Heart, Lung, and Blood Institute |

phs000179.v7.p2.c1

phs000179.v7.p2.c2

| | NHLBI TOPMed - NHGRI CCDG: The Vanderbilt AF Ablation Registry | phs000997.v6.p3.c1 | | Collaborative Cohort of Cohorts for COVID-19 Research (C4R): Jackson Heart Study (JHS) |

phs002907.v2.p2.c1

phs002907.v2.p2.c2

phs002907.v2.p2.c3

phs002907.v2.p2.c4


| | Collaborative Cohort of Cohorts for COVID-19 Research (C4R): Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS) |

phs002909.v2.p1.c1

phs002909.v2.p1.c2

phs002909.v2.p1.c3

phs002909.v2.p1.c4

phs002909.v2.p1.c5

phs002909.v2.p1.c6

phs002909.v2.p1.c7

phs002909.v2.p1.c8

| #### Upcoming Data Releases The table below highlights studies that are planned for release in August | Study Name | phs I.D. # | | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ | |


Clonal Evolution of Pre-Leukemic Hematopoietic Stem Cells Precedes Human Acute Myeloid Leukemia

| phs000549.v1.p1.c1 | | Consortium on Asthma among African-ancestry Populations in the Americas (CAAPA) |

phs001123.v2.p1.c1

phs001123.v2.p1.c2

phs001123.v2.p1.c3

phs001123.v2.p1.c4

phs001123.v2.p1.c5

phs001123.v2.p1.c6

phs001123.v2.p1.c7


| |

Idiopathic Multicentric Castleman Disease Whole Genome Sequencing Project


| phs001706.v1.p1.c1 | | Caregiving as a Natural Stressor in Studies of the Role of Genes That Affect Serotonin Function in Regulating Risk Factors for Coronary Heart Disease (CAREGIVER) | phs001747.v1.p1.c1 | |


Asthma in the Lives of Families Today (ALOFT)

| phs002182.v4.p1.c1 | | NHLBI TOPMed: Pulmonary Vascular Disease Phenomics Program (PVDOMICS) | phs002451.v1.p1.c1 | | Bulk RNA Sequencing of 86 Human Donor Lungs | phs002484.v1.p1.c1 | | Coagulation and Fibrinolysis in a Pediatric Insulin Titration Trial | phs003016.v1.p1.c1 | | Cellular Indexing of Transcriptomes and Epitopes Sequencing (CITE-Seq) Analysis to Investigate the Impact of Granulocyte-Colony Stimulating Factor on CRISPR/Cas9 Gene Edited Human Hematopoietic Stem Cell Function | phs003277.v1.p1.c1 | | Circulating RNAs in Acute Heart Failure (CRUCIAL) | phs003403.v1.p1.c1 | | Cellular and Molecular Investigations of Human Hearts | phs003473.v1.p1.c1 | | Cell Type-Specific and Disease-Associated eQTL in the Human Lung |

phs003521.v1.p1.c1

phs003521.v1.p1.c2

| | Comprehensive Single-Cell Multiomic Profiling of the Human Heart in Health and Disease | phs004650.v1.p1.c1 | | Cardiovascular Cell Therapy Research Network (CCTRN)-LateTIME | phs004663.v1.p1.c1 | | Cardiothoracic Surgical Trials Network (CTSN) Evaluation of Outcomes Following Mitral Valve Repair/Replacement in Severe Chronic Ischemic Mitral Regurgitation (SMR)(CTSN-SMR-BioLINCC) | phs004664.v1.p1.c1 | | Rule Out Myocardial Ischemia/Infarction by Computer Assisted Tomography (ROMICAT-II-BioLINCC) | phs004665.v1.p1.c1 | | Cardiovascular Cell Therapy Research Network (CCTRN) Clinical and MR Imaging Assessments in Patients With Intermittent Claudication Following Injection of Bone Marrow Derived ALDH Bright Cells (PACE-BioLINCC) | phs004667.v1.p1.c1 | | Blood and Marrow Clinical Trials Network - Trial of Tandem Autologous Stem Cell Transplants +/- Post Second Autologous Transplant Maintenance Therapy for Patients With Multiple Myeloma (BMT-CTN-0102-BioLINCC) | phs004672.v1.p1.c1 | | Coronary Drug Project (CDP-BioLINCC) | phs004674.v1.p1.c1 | | Cardiothoracic Surgical Trials Network (CTSN) Rate Control Versus Rhythm Control For Postoperative Atrial Fibrillation (POAF-BioLINCC) | phs004678.v2.p2.c1 | | Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care (ICARE-BioLINCC) | phs004679.v1.p1.c1 | | Blood and Marrow Clinical Trials Network - A Trial Comparing Allogeneic Hematopoietic Cell Transplant to Hypomethylating Therapy or Best Supportive Care in Patients with Intermediate-2 & High Risk Myelodysplastic Syndrome (BMT CTN-1102-BioLINCC) | phs004700.v1.p1.c1 | | International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA)- Chronic Kidney Disease (ISCHEMIA-CKD-BioLINCC) | phs004706.v1.p1.c1 | | Cardiothoracic Surgical Trials Network (CTSN) Surgical Interventions for Moderate Ischemic Mitral Regurgitation (CTSN-MMR-BioLINCC) | phs004708.v1.p1.c1 | | Cardiothoracic Surgical Trials Network - Surgical Ablation Versus No Surgical Ablation for Patients With Atrial Fibrillation Undergoing Mitral Valve Surgery (CTSN-AFB-BioLINCC) | phs004713.v1.p1.c1 | | Beta-Blocker Heart Attack Trial (BHAT-BioLINCC) | phs004717.v1.p1.c1 | | Transfusion of Prematures Trial: Does a Liberal Red Blood Cell Transfusion Strategy Improve Neurologically-Intact Survival of Extremely-Low-Birth-Weight Infants as Compared to a Restrictive Strategy? (TOP-BioLINCC) | phs004723.v1.p1.c1 | | American Trial Using Tranexamic Acid in Thrombocytopenia (A-TREAT-BioLINCC) | phs004724.v1.p1.c1 | | :Catheter Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation Trial (CABANA-BioLINCC) | phs004371.v1.p1.c1 | | Trial of Roflumilast in Asthma Management (TRIM) | phs004732.v1.p1.c1 | | Childhood Asthma Management Program (CAMP-BioLINCC) | phs004733.v1.p1.c1 | | Childhood Asthma Research and Education Network Trial - Prevention of Early Asthma in Kids (CARE-PEAK-BioLINCC) | phs004734.v1.p1.c1 | |

Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA)


| phs004735.v1.p1.c1 | | Registry Evaluation of Vital Information for VADs in Ambulatory Life (REVIVAL-BioLINCC) | phs004738.v1.p1.c1 | | Trial of Activity for Adolescent Girls (TAAG-BioLINCC) | phs004741.v1.p1.c1 | | Aging and Cognitive Health Evaluation in Elders (ACHIEVE-BioLINCC) |

phs004756.v1.p1.c1

phs004756.v1.p1.c2

| |

The Jackson Heart Study (JHS)


|

phs000964.v6.p2.c1

phs000964.v6.p2.c2

phs000964.v6.p2.c3

phs000964.v6.p2.c4

| | NHLBI TOPMed: Heart and Vascular Health Study (HVH) |

phs000993.v6.p2.c1

phs000993.v6.p2.c2

| | NHLBI TOPMed: The Vanderbilt Atrial Fibrillation Registry (VU\_AF) | phs001032.v7.p2.c1 | | NHLBI TOPMed: HyperGEN - Genetics of Left Ventricular (LV) Hypertrophy |

phs001293.v4.p1.c1

phs001293.v4.p1.c2

| | NHLBI TOPMed: Pediatric Cardiac Genomics Consortium (PCGC)'s Congenital Heart Disease Biobank |

phs001735.v3.p1.c1

phs001735.v3.p1.c2

| | NHLBI Growth and Health Study (NGHS) | phs004467.v2.p1.c1 |
For detailed platform release notes please consult the following resources: * Gen3 release notes * [Terra release notes](https://support.terra.bio/hc/en-us/sections/4414878945819-Release-Notes) * [Seven Bridges release notes](https://sb-biodatacatalyst.readme.io/changelog/) * [PIC-SURE release notes](https://pic-sure.gitbook.io/nhlbi-biodata-catalyst-powered-by-pic-sure/release-notes/release-notes)